Aug 26, 2013 ... Jackie Ruiz v. Merck & Company, Inc., et al., C.A. No. ... Amylin Pharmaceuticals,
Inc., et al., C.A. No.3:12-02566 ... Angelo Consilvio v. Merck ...
Jul 5, 2012 ... Maspero et al. in a 6-month, open-label extension study compared the efficacy ...
The MOSAIC study (MLK Study of Asthma in Children, sponsored by Merck & Co.
) ... by a pharmaceutical company (GlaxoSmithKline Inc.) compared the .....
Montelukast vs. inhaled low-dose budesonide as monotherapy in the ...
Nov 11, 2015 ... Recently, Fey and et al. evaluated the efficacy and safety of montelukast ... Merck
& Co. ... 2012. https://www.merck.com/product/usa/pi_circulars/s/singulair/
singulair_ppi.pdf. ... Ghorwade V, Patil A, Patil S, Srikonda K, Kotagiri R, Patel P.
... Cingolani A, Consilvio NP, Verini M, Chiarelli F. Montelukast versus...
Mar 2, 2005 ... Inc., 2003; on September 30, 2004, Merck & Co. Inc. .... reduction in the incidence
of AD in the rofecoxib group vs the placebo group with two-tailed alpha ..... et al,
2003; Qin et al, 2003; Consilvio et al, 2004; Rose et al, 2004).
Oct 2, 2012 ... 1651 Ex Parte Demmer et al 10516405 - (D) SCHEINER 103 CHERNOFF, ...
NETAPP, INC., Patent Owner and Appellant 95000328 6892211 .... 1725 THE
LINCOLN ELECTRIC COMPANY Requester and Respondent v. ... (D)
WEINBERG 102 102/103 GENTEX CORPORATION CONSILVIO, MARK J
May 17, 2013 ... approval is pending review.6 The first generic company to file such a patent
challenge .... 14 See Mark Consilvio & Jonathan R.K. Stroud, Unraveling the ....
Merck's anti-hypertension drugs Cozaar and Hyzaar, Merck .... Inc. v. Helsinn
Healthcare S.A. et. al., PGR2014-00010, Paper 1 (P.T.A.B. Sept. 2, 2014) ...
Gryboski and Powell et al. described infants presenting in the first 6 weeks of life
with ... Reports of series of infants with FPIES by Sicherer et al. ..... and
Thermofisher Scientific, and for advisory board activities from Merck and
Stallergens. .... Monti G, Viola S, Tarasco V, et al. .... Scaparrotta A, Di Pillo S,
Consilvio NP, ...
Cite this article as: Toledano, A., Álvarez, M.I., Caballero, I. et al. J Neural Transm
(2008) 115: 1093. doi:10.1007/s00702-008-0040-9. 1 Citations; 66 Downloads ...
et al.  (43 patients) further characterized clinical features. and modiﬁed food
challenge protocols. More recent ..... index is not consistently different from
control, non-allergic. subjects ... ﬁnding for patients presenting with acute FPIES
a nd inc luded it. as one of .... Sopo SM, Filoni S, Giorgio V, Monaco S, Onesimo
contributes to neuronal cell death (Consilvio et al., 2004; Manabe et al., 2004). ....
9-b-D-arabinofuranoside (Ara A) were purchased from Merck ... primary
microglial cell cultures with a v-raf/v-myc oncogene car- ... Inc, Taipei, Taiwan).
..... microglia via NF-kappaB and AP-1 co-regulation of COX-2 expression by